You have 9 free searches left this month | for more free features.

Acute Myelogenous Leukemia (AML)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

Recruiting
  • Breast Cancer
  • +4 more
  • Web bases survey
  • Canton, Ohio
    Cleveland Clinic Mercy Hospital
Aug 2, 2023

Acute Myelogenous Leukemia (AML) Trial in Australia (MAX-40279)

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • Darlinghurst, New South Wales, Australia
  • +3 more
Jan 18, 2022

Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Orange, California
  • +2 more
Nov 30, 2022

Pediatric Acute Myelogenous Leukemia (AML) Trial in Australia, Canada, United States (Decitabine)

Terminated
  • Pediatric Acute Myelogenous Leukemia (AML)
  • Phoenix, Arizona
  • +21 more
Jun 24, 2022

Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

Recruiting
  • Breast Cancer
  • +4 more
  • Web based survey
  • New Haven, Connecticut
  • +6 more
Aug 8, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

AML Trial in Hangzhou (MAX-40279-01)

Recruiting
  • AML
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 18, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

Terminated
  • Acute Myelogenous Leukemia
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Mar 17, 2022

Acute Myelogenous Leukemia (AML) Trial in Philadelphia (Eltrombopag)

Terminated
  • Acute Myelogenous Leukemia (AML)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 14, 2021

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Miami, Florida
    University of Miami
Dec 7, 2021

MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes (MDS)
  • Acute Myelogenous Leukemia (AML)
  • low dose 5'-azacitidine
  • Basking Ridge, New Jersey
  • +6 more
Dec 1, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
Sep 26, 2022

Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,

Terminated
  • Leukemia
  • +2 more
  • Ciprofloxacin 750 MG
  • +3 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
Jul 5, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +4 more
Sep 14, 2021

Acute Myeloid Leukemia Trial in Ramat Gan (CAR-T CD19)

Recruiting
  • Acute Myeloid Leukemia
  • CAR-T CD19
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Oct 30, 2022

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

Acute Myeloid Leukemia Trial in Toronto (IL-12)

Recruiting
  • Acute Myeloid Leukemia
  • IL-12
  • Toronto, Ontario, Canada
    Princess Margaret Centre Centre
Apr 16, 2021

Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Leipzig, Germany
    Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

Terminated
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Boston, Massachusetts
  • +5 more
Jun 11, 2021

Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • AML
  • DC AML Vaccine
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 25, 2022

Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

Completed
  • Acute Myelogenous Leukemia
  • Rochester, New York
    University of Rochester
Jul 1, 2022

AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

Recruiting
  • AML
  • +4 more
  • CD123-CAR T
  • +4 more
  • Memphis, Tennessee
  • +1 more
May 10, 2022

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023